EZH2 and central nervous system cancer: Gliomas with BRAF gains commonly had concomitant gains in MET, SMO, EZH2, and CDK6 (p < 0.001 each; Supplementary Table 2), along with other genes on 7q, which may reflect larger chromosomal duplications (Fig. 3b).